Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway.
about
Protein phosphorylation cascades associated with methamphetamine-induced glial activation.Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradationRapamycin inhibits didemnin B-induced apoptosis in human HL-60 cells: evidence for the possible involvement of FK506-binding protein 25Adenosine kinase regulation of cardiomyocyte hypertrophy.Insulin activates a PD 098059-sensitive kinase that is involved in the regulation of p70S6K and PHAS-I.p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.Differential activation of p70 and p85 S6 kinase isoforms during cardiac hypertrophy in the adult mammal.Raf-1 signaling is required for the later stages of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells but is not mediated by the MEK/ERK moduleRaf and fibroblast growth factor phosphorylate Elk1 and activate the serum response element of the immediate early gene pip92 by mitogen-activated protein kinase-independent as well as -dependent signaling pathways.4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle.Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis.[Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway.The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal.Raf-1 activation prevents caspase 9 processing downstream of apoptosome formation.A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of RasRibonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential.Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.PI3 K/Akt/mTOR-mediated translational control regulates proliferation and differentiation of lineage-restricted RoSH stem cell lines.Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins.Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation.A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation.The mitogen-activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB.Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.The activated glucocorticoid receptor modulates presumptive autoregulation of ribosomal protein S6 protein kinase, p70 S6K.Farnesyltransferase inhibitor induces rapid growth arrest and blocks p70s6k activation by multiple stimuli.MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells.Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras.Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry.Ras- and Raf-induced down-modulation of non-muscle tropomyosin are MEK-independent.Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells.The p42/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+/H+ exchanger (NHE1 isoform) in response to growth factors.p70s6k is activated by CCK in rat pancreatic acini.Feedback regulation of Raf-1 and mitogen-activated protein kinase (MAP) kinase kinases 1 and 2 by MAP kinase phosphatase-1 (MKP-1).Indinavir impairs protein synthesis and phosphorylations of MAPKs in mouse C2C12 myocytes.Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway.Uncoupling Raf1 from MEK1/2 impairs only a subset of cellular responses to Raf activation.Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translation.
P2860
Q23918164-CD7F0D69-23E9-4B37-B4CE-89CFA2AFD41CQ24534560-4F0DFA0A-0564-47E3-874D-CF33BFEAC7A5Q24557574-CAF5D083-9580-4C95-B524-8CE15030EE78Q28377538-0C624D14-7FCC-4380-8243-97AC932BD8C5Q29347052-78DD013E-DECA-41FB-BE35-C3121EB12EEAQ30470683-0B8D3B8D-E2D3-4FFA-A0E9-4BEC939AA77AQ30847612-73FECEBC-2D55-4E2D-BC6F-BF8BAC4A764EQ32023669-DAF5E31F-1AFE-439F-ABBD-FFFB6F230764Q33622872-4B8FCDE4-B712-4AF2-9AAD-69287BECDD13Q33996268-A0DA3B48-E9F4-43AD-99C3-70EE495F3472Q34043002-1EBB18E8-2759-441A-ACD8-1383A1EE85C8Q34249203-F888F13B-5E0C-444A-B489-E70714272117Q34459460-88B9F8B9-1F19-492C-9F34-1E6F6D7B27CAQ34699388-C6756A91-7F66-4CA7-A95B-DEF1E61436D9Q35001227-28A4BEA9-A00F-456E-A886-54A3E1388D5AQ35572415-26EB81A3-B2DA-4E35-B711-B38FC26CD063Q35941503-BDF902DB-FD5E-45C6-8FA9-7967E66BAED1Q36095781-B06F933E-50AA-44D4-88B3-24FC2D5B8764Q36098154-CE2CDA53-897E-4206-B8FD-DDEAC20EAD9CQ36288233-4198C67E-9751-411A-B630-6DBC0CC3CCA1Q39446908-ED1A139C-FDC3-453A-B788-BB8E2D37BE37Q39732365-69FCE69D-F8A8-406B-BC99-62CA40944C29Q39756106-C2A854BA-CF3A-4AD0-8D54-4703DEE40871Q40565030-BDEFCFC1-2FE5-4399-A5C0-8A810F405025Q40769038-C7F06F7E-B331-4BC7-8395-4B97191DFFAFQ40831741-D0B392BE-7336-4D72-A6D1-B2815BC3F39EQ40923873-2CB7FD2D-FF46-4FF4-AAF0-9104A509093CQ40928369-65C1BE04-A374-4F40-A992-4D203561FBD5Q40976467-A7B08CDA-27F2-48F2-AC91-AC3CAEBDE05CQ40993730-5E1ADC48-244F-4D17-AB08-BF7D1F1EC3ACQ41089150-240D705C-C748-4BE5-89A4-02305E3C5272Q41135262-562EABA1-9F07-492C-B953-A112A1BD0308Q42442521-17485F68-64C0-487A-9A29-052BAE982ACDQ42449463-410F77F4-AB4B-4B47-AEB9-1C1CBF053B7EQ42464012-84B5A094-9889-4916-9361-CE53BD655D29Q42524076-A06AF50B-27FB-4340-9C62-3BC9116F2911Q42835325-3D047DE1-8747-40C3-93AE-6A99D31B2164Q45065669-46B6D670-3405-43BA-950B-4C50CB042F1E
P2860
Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Oncogenic Raf-1 activates p70 ...... in kinase-independent pathway.
@en
type
label
Oncogenic Raf-1 activates p70 ...... in kinase-independent pathway.
@en
prefLabel
Oncogenic Raf-1 activates p70 ...... in kinase-independent pathway.
@en
P2093
P2860
P356
P1476
Oncogenic Raf-1 activates p70 ...... in kinase-independent pathway.
@en
P2093
Lenormand P
Pouysségur J
P2860
P304
15762-15768
P356
10.1074/JBC.271.26.15762
P407
P577
1996-06-01T00:00:00Z